Castleark Management’s Adient ADNT Stock Holding History

Castleark Management’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-92,780	Closed	-$4.44M	–	322
2021 Q4	$4.44M	Buy	+92,780	New	+$4.16M	0.16%	140

Other funds holding ADNT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

LAM

Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Castleark Management's ADNT Position: Q1 2022 in Review

Castleark Management sold out of Adient (ADNT) in Q1 2022, closing a stake of 92,780 shares — an estimated $4.44M sold.

Castleark Management first reported a position in ADNT in Q4 2021 and held it in 1 quarter. The position peaked at $4.44M in Q4 2021. 270 funds tracked by Wall St. Rank hold ADNT as of Q1 2022.

Castleark Management reported no remaining Adient position as of Q1 2022 after selling out during the quarter.
Castleark Management sold 92,780 Adient shares in Q1 2022, an estimated $4.44M.
Castleark Management first reported a position in Adient in Q4 2021 and held it in 1 quarter.
Castleark Management's Adient position peaked at $4.44M in Q4 2021.
270 funds tracked by Wall St. Rank held Adient as of Q1 2022.

Based on Castleark Management's 13F filing for Q1 2022, filed 16 May 2022.